Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08891_nanopub.RAVp2nUNb9PU86pu4_vwUWKWweAYakTWtuWadWAZpbw9o#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB08891 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08891 label "Arbaclofen [drugbank:DB08891]" assertion.
- drugbank:DB08891 seeAlso DB08891 assertion.
- drugbank:DB08891 description "Arbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as a treatment for spasticity due to multiple sclerosis and spinal cord injury. Arbaclofen was investigated as a treatment for gastroesophageal reflux disease (GERD); however, with disappointing results." assertion.
- drugbank:DB08891 identifier "drugbank:DB08891" assertion.
- drugbank:DB08891 title "Arbaclofen" assertion.
- drugbank:DB08891 drugbank_vocabulary:x-cas cas:69308-37-8 assertion.
- drugbank:DB08891 drugbank_vocabulary:drugbank-id "DB08891" assertion.
- drugbank:DB08891 bio2rdf_vocabulary:x-identifiers.org DB08891 assertion.
- drugbank:DB08891 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08891" assertion.
- drugbank:DB08891 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08891 bio2rdf_vocabulary:identifier "DB08891" assertion.